1
Total Mentions
1
Documents
0
Connected Entities
Organization referenced in documents
EFTA02714282
o Health OPK US Isis Pharma ISIS US Avg RNAI (late stage) $63.97 $9.08 $42.90 $4,088.8 $3,652.0 $4,873.8 54,204.87 $63.97 $9.08 $42.90 Avg Total $2,355 6 'Page EFTA_R1_02 139721 EFTA02714287 BREMNER CAP I TAL NIANAGEIVIENT Tekmira Pharmaceuticals March 2014 Ownership — shareholder s
No connected entities